tiprankstipranks
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX

BioCryst (BCRX) Ownership - Who Owns BioCryst?

1,956 Followers

BioCryst (BCRX) Ownership Overview

13.64%19.35%21.39%45.63%
13.64% Insiders
21.39% Other Institutional Investors
45.63% Public Companies and
Individual Investors
The ownership structure of BioCryst (BCRX) stock is a mix of institutional, retail and individual investors. Approximately 40.74% of the company’s stock is owned by Institutional Investors, 13.64% is owned by Insiders and 45.63% is owned by Public Companies and Individual Investors.
The ownership structure of BioCryst (BCRX) stock is a mix of institutional, retail and individual investors. Approximately 40.74% of the company’s stock is owned by Institutional Investors, 13.64% is owned by Insiders and 45.63% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 15, 2023Sold$31920
Jun 15, 2023
Nancy Hutson
Director
Sold$103443

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$32369
Dec 31, 2023Bought$388487
Dec 31, 2023Sold$3207992
Dec 31, 2023Sold$17275741

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
15,330,671Institution7.44%67,148,339
15,063,285Insider7.31%65,977,188
14,216,299Institution6.90%62,267,390
13,086,486Institution6.35%57,318,809
10,126,176Institution4.91%44,352,651
9,144,488Institution4.44%40,052,857
4,539,525Institution2.20%19,883,120
2,884,097Institution1.40%12,632,345
2,645,000Institution1.28%11,585,100
2,581,481Institution1.25%11,306,887

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
14,216,299Institution6.90%62,267,390
2,645,000Institution1.28%11,585,100
2,581,481Institution1.25%11,306,887
2,074,536Institution1.01%9,086,468
2,032,549Institution0.99%8,902,565
1,896,273Institution0.92%8,305,676
1,770,554Institution0.86%7,755,027
1,123,400Institution0.54%4,920,492
970,450Institution0.47%4,250,571
891,794Institution0.43%3,906,058

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
12,810,487Institution6.21%56,750,457
6,440,317Institution3.12%32,716,810
4,450,427Institution2.16%19,626,383
3,159,306Institution1.53%16,049,274
2,605,914Institution1.26%13,238,043
1,478,900Institution0.72%7,512,812
1,488,588Institution0.72%6,564,673
1,208,466Institution0.59%5,329,335
966,108Institution0.47%4,279,858
705,478Institution0.34%3,583,828

FAQ

Who Owns Biocryst Pharmaceuticals (BCRX)?
According to the latest TipRanks data, approximately 21.39% of the company's stock is held by institutional investors, 13.64% is held by insiders, and 45.63% is held by retail investors.
    What percentage of Biocryst Pharmaceuticals (BCRX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 21.39% of Biocryst Pharmaceuticals (BCRX) stock is held by institutional investors.
      What percentage of Biocryst Pharmaceuticals (BCRX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 45.63% of Biocryst Pharmaceuticals (BCRX) stock is held by retail investors.
        Who owns the most shares of Biocryst Pharmaceuticals (BCRX)?
        Vanguard owns the most shares of Biocryst Pharmaceuticals (BCRX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis